ArticleBMC surgery2025
Thoracoscopic management of recurrent tracheoesophageal fistula: a single-center outcome analysis.
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAlthough thoracoscopic treatment of congenital esophageal atresia is widely accepted among pediatric surgeons, its application in recurrent tracheoesophageal fistula (RTEF) remains rare because of its technical difficulty. This study retrospectively analyzed thoracoscopic RTEF repairs at a single center to evaluate the safety, feasibility, and outcomes of this approach, providing a clinical reference.
methodsWe retrospectively reviewed 22 patients with RTEF who underwent thoracoscopic repair at the Capital Center for Children's Health between October 2020 and July 2024. All patients had a history of type III esophageal atresia repair, including 13 cases of type IIIa and 9 cases of type IIIb (Gross classification). The cohort included 8 male and 14 female patients, with an admission age of 2 to 30 months (mean: 8.0 ± 7.2) and weight of 2.3 to 11.0 kg (mean: 5.5 ± 2.4). There were 16 first recurrences, 5 s recurrences, and 1 fourth recurrence. Five patients had failed previous endoscopic fistula ligation, and 9 had a history of open thoracotomy. All 22 underwent thoracoscopic repair.
resultsThoracoscopic RTEF repair was successfully completed in all 22 patients (100%). The operation time ranged from 136 to 420 min (mean: 288.5 ± 93.1), hospitalization ranged from 15 to 124 days (median: 24), and postoperative invasive ventilator support lasted 0 to 480 h (median: 20). Esophageal leakage occurred in 6 patients (27.3%), all of whom recovered with 1 to 8 weeks of conservative treatment. Esophageal stenosis developed in 8 patients (36.4%), including 6 pre-existing and 2 new-onset cases; all improved after 1 to 6 sessions of endoscopic balloon dilation. During follow-up (0.5–4 years), only 1 patient (4.5%) experienced re-recurrence; the remaining patients showed good growth and development.
conclusionThoracoscopic treatment of RTEF following esophageal atresia is safe, feasible, and yields satisfactory clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.